<DOC>
	<DOCNO>NCT02094196</DOCNO>
	<brief_summary>The aim project ass reward- base learn behavior association alteration dopaminergic glutamatergic transmission detoxify alcohol-dependent patient match control . The investigator explore alteration interact clinical psychosocial factor modify relapse risk learn deficit . Patients detoxified inpatient setting . Clinical assessment , behavioral paradigm learn brain imaging carry within least 4 half- life psychotropic medication . The investigator implement apply functional imaging paradigm assess Pavlovian-to-instrumental transfer reversal learn task associate model parameter learn alcohol craving , intake prospective relapse risk . In project , impact dopamine x glutamate interaction learn deficit consecutive relapse probability target [ 18F ] fallypride PET measurement absolute concentration glutamate magnetic resonance spectroscopy ( MRS ) .</brief_summary>
	<brief_title>The Role Dopaminergic Glutamatergic Neurotransmission Dysfunctional Learning Alcohol Use Disorders</brief_title>
	<detailed_description>Alcohol consumption despite negative consequence may rely impaired flexibility adapt behavior environmental change , i.e . learn response reward contingency . This learn deficit clinical relevance particularly therapy psychosocial outcome . The reduced availability central dopamine D2-receptors detoxify alcohol dependent patient observe PET investigation hypothetical effect reward-related learning line evidence learn deficit hypodopaminergic state , particularly avoidance learn non-dependent sample . Growing evidence indicate learning-related striatal dopamine signal modulate higher executive function involve , e.g. , prefrontal cortex . Here , broad glutamatergic output prefrontal cortex crucial subcortical learn mechanism match recent model interactive dopamine-glutamate dysfunction model neurotrophic signal alcohol dependence .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Dopamine Agonists</mesh_term>
	<criteria>Alcohol dependence accord DSMIV Minimum 72 hour abstinence , maximum 21 day abstinence Minimum three year alcohol dependence Low severity withdrawal symptom Ability provide fully inform consent use self rating scale Lifetime history DSM IV bipolar psychotic disorder Current threshold DSMIV diagnosis follow disorder : current major depressive disorder , generalize anxiety disorder , PTSD , borderline personality disorder obsessive compulsive disorder History substance dependence alcohol nicotine dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Reward- base learning</keyword>
	<keyword>Pavlovian-to-instrumental transfer</keyword>
	<keyword>Relapse Risk</keyword>
	<keyword>Positron emission tomography ( PET )</keyword>
	<keyword>Magnetic resonance spectroscopy ( MRS )</keyword>
	<keyword>Dopamine receptor availability</keyword>
	<keyword>Glutamate</keyword>
</DOC>